Comparison of ADC Metrics and Their Association With Outcome for Patients With Newly Diagnosed Glioblastoma Being Treated With Radiation Therapy, Temozolomide, Erlotinib and Bevacizumab
Journal of Neuro-Oncology - Netherlands
doi 10.1007/s11060-014-1636-6
Full Text
Open PDFAbstract
Available in full text
Date
October 29, 2014
Authors
Publisher
Springer Science and Business Media LLC